Venmax Drugs & Pharmaceuticals Share Price Today | Stock Price & Venmax Drugs & Pharmaceuticals Share Screener

Track the current stock price of Venmax Drugs & Pharmaceuticals with an interactive chart. Analyse VENMAX share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Venmax Drugs & Pharmaceuticals stock quote in one place.

The quote of ₹14.44 sits between the 52-week low of ₹13.60 and the 52-week high of ₹30.10, and the latest session moved -0.41% from the previous close.

Screen Venmax Drugs & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VENMAX shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE154G01022.

Classification

Identifiers and Leadership

Screen VENMAX balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹16, up from ₹5 in 2025.

Latest statistics put total assets at ₹16 and shareholder funds at ₹14, with a leverage ratio of 0.02.

Screen Venmax Drugs & Pharmaceuticals income statement and profit fundamentals. Analyze VENMAX quarterly results. Venmax Drugs & Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹9 and net profit was ₹0, equal to earnings per unit of ₹0.40, at an operating margin of 2%.

In that period expenses were ₹9, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹8 and net profit of ₹0.

Screen VENMAX cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹11, and net cash flow was an outflow of ₹1.

Over the same period, investing activities provided ₹0 and financing activities provided ₹10.

See Venmax Drugs & Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Venmax Drugs & Pharmaceuticals promoter holding and ownership changes for VENMAX on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 10.46%, foreign institutions 0.00%, domestic institutions 0.00% and the public 74.34%, spread across 6,865 shareholders.

The shareholder count was 6,865 in 2026-Jun, compared with 6,802 in 2026-Mar.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Venmax Drugs & Pharmaceuticals. Venmax Drugs & Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

See which indices include Venmax Drugs & Pharmaceuticals stock. Check VENMAX index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Venmax Drugs & Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Venmax Drugs & Pharmaceuticals stock events that may affect VENMAX share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Extraordinary General Meeting dated October 24, 2026, with a record date of October 24, 2026.

It is followed by Annual General Meeting dated September 26, 2026 and Quarterly Result Announcement dated August 7, 2026.

Screen VENMAX competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen VENMAX latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 30, 2026.

The next most recent announcements are dated September 27, 2026 and September 27, 2026.

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.